SCHEMBL5407259

SCHEMBL5407259

CC(C)c1cccc(C(C)C)c1NC(C)(C)c1ccccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 1/20 0.40
HDAC6 Q9UBN7 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 2/20 0.36
KMT2A Q03164 1/20 0.36
NMBR P28336 1/20 0.36
GABRA1 P14867 2/20 0.35
GABRB2 P47870 2/20 0.35
CCR4 P51679 1/20 0.34
P2RY1 P47900 1/20 0.33
ADORA2A P29274 1/20 0.33
FAAH O00519 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
GABRB1 P18505 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5840008 0.82 SLC40A1 (0.39) SLC40A1HDAC6SMN1; SMN2L3MBTL1LMNA
SCHEMBL16177012 0.78 CCR4 (0.34) SLC40A1SMN1; SMN2LMNAKMT2AGABRA1
SCHEMBL19862563 0.74 SMN1; SMN2 (0.47) HDAC6SMN1; SMN2L3MBTL1LMNACYP1A2
SCHEMBL17620907 0.74 EGFR (0.42) LMNAKMT2AGABRA1GABRB2ADORA2A
SCHEMBL28750279 0.72 CETP (0.37) SLC40A1LMNAKMT2ANMBR
SCHEMBL28959946 0.71 LMNA (0.38) SMN1; SMN2LMNAKMT2AGABRA1GABRB2
SCHEMBL14954640 0.70 KMT2A (0.50) SMN1; SMN2L3MBTL1LMNAKMT2AGABRA1
SCHEMBL2055586 0.70 SMN1; SMN2 (0.50) HDAC6SMN1; SMN2L3MBTL1LMNAADORA2A
SCHEMBL21323881 0.70 KDM4E (0.42) KMT2AADORA2A
SCHEMBL21158254 0.69 GABRA1 (0.41) SMN1; SMN2LMNAKMT2AGABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050170950-A1 Mixed catalyst compositions for the production of polyolefins W. R. GRACE & CO.-CONN. 2005-08-04 US claimed
EP-1504042-A2 MIXED CATALYST COMPOSITIONS FOR THE PRODUCTION OF POLYOLEFINS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2005-02-09 EP claimed
WO-2003095508-A2 MIXED CATALYST COMPOSITIONS FOR THE PRODUCTION OF POLYOLEFINS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2003-11-20 WO claimed
US-7166553-B2 Mixed catalyst compositions for the production of polyolefins UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2007-01-23 US disclosed
US-6927263-B2 Catalyst precursor and olefin polymerization processes UNIVATION TECHNOLOGIES, LLC (US) 2005-08-09 US disclosed
US-20050170950-A1 Mixed catalyst compositions for the production of polyolefins W. R. GRACE & CO.-CONN. 2005-08-04 US disclosed
EP-1504042-A2 MIXED CATALYST COMPOSITIONS FOR THE PRODUCTION OF POLYOLEFINS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2005-02-09 EP disclosed
US-20040039140-A1 Catalyst precursor and olefin polymerization processes PETERSON THOMAS H (US) 2004-02-26 US disclosed
US-6653417-B2 Catalyst precursor and olefin polymerization processes UNIVATION TECHNOLOGIES, LLC 2003-11-25 US disclosed
WO-2003095508-A2 MIXED CATALYST COMPOSITIONS FOR THE PRODUCTION OF POLYOLEFINS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2003-11-20 WO disclosed
US-20030105254-A1 Catalyst precursor and olefin polymerization processes UNIVATION TECHNOLOGIES, LLC 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105254-A1 Catalyst precursor and olefin polymerization processes PCNA, PARP6, PARP16 SLC40A1 3432/4885HDAC6 1981/4885SMN1; SMN2 3757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.